Alibaba Health Information Technology Limited Return on Equity

Alibaba Health Information Technology Limited posts a ROE of 8.42%. That is below the Healthcare sector average of 13.26%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

For Healthcare stocks, a ROE near 13.26% is typical. Alibaba Health Information Technology Limited's 8.42% is lower that level. That is roughly 36.6% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Alibaba Health Information Technology Limited's ROE moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is 8.42%; use YoY and peer views to separate noise from signal.

Context for ALBBY's ROE usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 13.26%), and (3) consistency with growth and profitability. This page covers the first two; Alibaba Health Information Technology Limited's other metric pages and overview cover the third.

Judging Alibaba Health Information Technology Limited against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in ROE easier to interpret. Start with 8.42% here, then scan peer and history charts to see if the gap is persistent.